Latest Guidelines for Hypertension Management (2025)
According to the most recent guidelines, hypertension management should target a systolic blood pressure of 120-129 mmHg and diastolic blood pressure of 70-79 mmHg for most adults, with treatment decisions based on cardiovascular risk assessment and comorbidities. 1
Diagnosis and Classification
- Definition: Hypertension is defined as BP ≥140/90 mmHg
- Measurement:
- Use validated automated upper arm cuff device with appropriate cuff size
- At first visit, measure BP in both arms; use arm with higher BP if consistent difference
- Confirm elevated office readings (≥130/85 mmHg) with home or ambulatory BP monitoring
- Office BP <130/85 mmHg: remeasure after 3 years
- Home BP threshold: ≥135/85 mmHg
- 24h ambulatory BP threshold: ≥130/80 mmHg 2, 1
Treatment Thresholds
Grade 1 Hypertension (140-159/90-99 mmHg):
- Start immediate drug treatment in high-risk patients (CVD, CKD, diabetes, organ damage, or aged 50-80 years)
- For low-moderate risk: Try lifestyle modifications for 3-6 months before initiating medications 2
Grade 2 Hypertension (≥160/100 mmHg):
- Start drug treatment immediately alongside lifestyle interventions 2
Elevated BP (120-139/70-89 mmHg):
- Cardiovascular risk assessment is crucial using SCORE2 (ages 40-69) or SCORE2-OP (≥70 years)
- Start medications after 3 months of lifestyle therapy for BP 130-139/80-89 mmHg in high-risk individuals 1
Treatment Targets
- Default target: 120-129/70-79 mmHg for most adults
- Modified targets for:
- Treatment intolerance
- Adults ≥85 years
- Symptomatic orthostasis
- Moderate-to-severe frailty
- Limited life expectancy 1
Lifestyle Modifications
All patients with BP ≥120/70 mmHg should implement:
- Sodium restriction to ~2g per day
- Regular physical activity (30-60 minutes, 4-7 days/week)
- Weight management (BMI 18.5-24.9 kg/m²)
- Mediterranean or DASH diet
- Limited alcohol consumption
- Smoking cessation
- Limited free sugar consumption (<10% of energy intake) 2, 1
Pharmacological Treatment Algorithm
Non-Black Patients:
- Start with low-dose ACEI/ARB
- Increase to full dose
- Add thiazide/thiazide-like diuretic
- Add spironolactone (or if not tolerated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker) 2
Black Patients:
- Start with low-dose ARB + DHP-CCB or DHP-CCB + thiazide-like diuretic
- Increase to full dose
- Add diuretic or ACEI/ARB
- Add spironolactone (or if not tolerated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker) 2
Simplification Strategies:
- Consider monotherapy only in low-risk grade 1 hypertension and patients >80 years or frail
- Prioritize once-daily dosing and single-pill combinations to improve adherence 2, 1
Special Populations
Diabetes or Chronic Kidney Disease:
- Target BP <130/80 mmHg
- First-line: ACEI/ARB (particularly with albuminuria)
- Without albuminuria: thiazides or dihydropyridine CCBs are also appropriate 2, 1
Cardiovascular Disease:
- For patients with angina, recent MI, or heart failure: beta-blockers and ACE inhibitors are recommended as first-line therapy 1
Monitoring and Follow-up
- Monitor BP control (achieve target within 3 months)
- Check renal function and electrolytes within 1-2 weeks after adding new agents, particularly ARBs or spironolactone
- Watch for orthostatic hypotension, especially in older adults
- If BP remains uncontrolled despite optimal therapy, refer to a provider with hypertension expertise 2, 1
Resistant Hypertension Management
- Definition: BP ≥140/90 mmHg despite three antihypertensive agents including a diuretic
- First-line agent for resistant hypertension: spironolactone
- Verify diagnosis by ensuring accurate BP measurements and medication adherence
- Rule out white coat effect with home or ambulatory monitoring
- Consider secondary causes of hypertension 1
Implementation Strategies
- Team-based care improves hypertension control
- Home BP monitoring enhances management
- Electronic health records and patient registries help identify uncontrolled hypertension
- Telehealth strategies can be useful adjuncts to BP-lowering interventions 1